tiprankstipranks
Advertisement
Advertisement

ABEO Stock Latest News

Arqit, American Eagle, Abeona, Vipshop, Verisign Shake-Up
Weekend UpdatesArqit, American Eagle, Abeona, Vipshop, Verisign Shake-Up
5d ago
AEO
ABEO
uniQure, Protara, Abeona, Cerebras, Verisign Insider Shake-Up
PremiumWeekend Updates
uniQure, Protara, Abeona, Cerebras, Verisign Insider Shake-Up
12d ago
ABEO
CBRS
Abeona Shareholders Back Board, Equity Plan at Meeting
PremiumCompany Announcements
Abeona Shareholders Back Board, Equity Plan at Meeting
1M ago
8K
ABEO
Abeona Therapeutics announces resignation of board member
PremiumCompany Announcements
Abeona Therapeutics announces resignation of board member
1M ago
8K
ABEO
Abeona Therapeutics Updates Investor Presentation Under Regulation FD
PremiumCompany Announcements
Abeona Therapeutics Updates Investor Presentation Under Regulation FD
1M ago
8K
ABEO
Abeona Advances ABO-701 T-Cell Therapy Toward IND
PremiumCompany AnnouncementsAbeona Advances ABO-701 T-Cell Therapy Toward IND
1M ago
8K
ABEO
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
Premium
Company Announcements
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
2M ago
ABEO
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
Premium
Company Announcements
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
2M ago
ABEO
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
PremiumThe Fly
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
2M ago
ABEO
ABEO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ABEO Upcoming Earnings Report: What to Expect?
2M ago
ABEO
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
PremiumCompany Announcements
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
3M ago
8K
ABEO
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
PremiumCompany Announcements
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
4M ago
8K
ABEO
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
PremiumRatingsEarly-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
4M ago
ABEO
Abeona Therapeutics Balances Big Windfall With Slow Ramp
Premium
Company Announcements
Abeona Therapeutics Balances Big Windfall With Slow Ramp
4M ago
ABEO
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
Premium
The Fly
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
4M ago
ABEO
Options Volatility and Implied Earnings Moves Today, March 17, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 17, 2026
4M ago
ASO
TME
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
PremiumThe Fly
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
4M ago
ABEO
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
4M ago
M
MU
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ABEO
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
PremiumRatingsEarly ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
4M ago
ABEO
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
Premium
Company Announcements
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
4M ago
8K
ABEO
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
Premium
The Fly
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
4M ago
ABEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >